Status:
RECRUITING
Trial to Evaluate the Clinical Utility of Non-invasive Endometrial Receptivity Test (Ora) in Patients With Implantation Failure
Lead Sponsor:
Inti Labs
Conditions:
IVF
Window of Implantation
Eligibility:
FEMALE
28-45 years
Phase:
NA
Brief Summary
The adjustment of the timing of embryo transfer based on the endometrial receptivity profile and transferring embryo(s) of good quality with normal chromosomes (diagnosed by Preimplantation Genetic Te...
Eligibility Criteria
Inclusion
- Experienced implantation failure with euploid or low-level mosaic (\< 30%) embryos in the past two years.
- Female age 28-45 years.
- Consent to undergo a simulated cycle for non-invasive optimal implantation window testing.
- Plan to undergo a frozen embryo transfer cycle.
- Have at least one euploid or low-level mosaic (\< 30%) frozen blastocyst.
Exclusion
- Presence of uterine cavity abnormalities that may affect implantation, such as polyps, fibroids ≧4 cm, or hydrosalpinx
- Presence of systemic diseases that may affect reproductive techniques (e.g., autoimmune diseases)
- Body mass index (BMI) over 30 kg/m²
Key Trial Info
Start Date :
June 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06544837
Start Date
June 22 2024
End Date
June 1 2027
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanoi Hospital
Hanoi, Vietnam